The Claim

Engineered Escherichia coli expressing surface-displayed ClbS reduces the fecal abundance of colibactin-producing E. coli NC101 by approximately 30-fold in mice.

Source: Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
40score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Quantitative
1 study reviewed
In plain English

A genetically modified strain of E. coli, designed to produce a protein that neutralizes colibactin, significantly lowers the levels of a harmful E. coli strain in the intestines of mice.

See the scientific wording

Engineered Escherichia coli expressing surface-displayed ClbS reduces the fecal abundance of colibactin-producing E. coli NC101 by approximately 30-fold in mice, suggesting that neutralizing colibactin may impair the competitive fitness of pks+ bacteria in the gut.

What the research says

1 study
  1. Study: Surface expression of antitoxin on engineered bacteria neutralizes genotoxic colibactin in the gut

    Scientists made harmless E. coli bacteria wear a special shield (ClbS) that neutralizes a toxic chemical made by harmful E. coli in the gut. This shield made the harmful bacteria weaker and less able to take over, which is exactly what the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.